ArticleArchives of virology2025
Recombination hotspots and genetic variability in foot-and-mouth disease virus genomes: a comparative genomic and phylogeographic analysis.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth disease virus (FMDV) poses a major threat to the global livestock economy. In this study, we analyzed 951 complete genome sequences of FMDV from 66 countries/regions reported from 1958 to 2023, using phylogenomics, recombination detection, and entropy analysis to elucidate its evolutionary dynamics. The phylogeny confirmed the grouping of isolates within the seven established serotypes (O, A, Asia1, C, SAT1, 2, and 3) with strong geographic clustering, and distinct subgenotypes were identified within serotypes O, A, Asia1, and SAT1. The genetic similarity was high (> 90%) within the serotypes but low (< 75%) between them, with the P1 capsid region showing the highest divergence. Interestingly, 117 probable recombination events were detected, predominantly involving serotypes O (n = 41) and A (n = 38), with 58.1% being inter-serotypic. Recombination hotspots were identified in non-structural regions (P2/P3), and the recombination frequency was markedly higher among the Asian and African isolates. Shannon entropy analysis revealed elevated amino acid variability in the structural proteins, notably VP1, of serotypes O and A. The study demonstrates that recombination is an important driver of FMDV diversity and adaptability, significantly affecting vaccine efficacy and outbreak patterns. These findings emphasize the critical need for global genomic surveillance to inform vaccine selection and control strategies.
Indexed as
Identifiers
41369708What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.